Skip to main content
GlaxoSmithkline Pharmaceuticals Ltd. logo

GlaxoSmithkline Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · GLAXO ISIN · INE159A01016 LEI · 3358002TNSC1U2DWNY52 BSE.NS Manufacturing
Open in API
Filings indexed 1,605 across all filing types
Latest filing 2025-12-22 Regulatory Filings
Country IN India
Listing BSE.NS GLAXO

About GlaxoSmithkline Pharmaceuticals Ltd.

https://india-pharma.gsk.com/en-in/home/

GlaxoSmithkline Pharmaceuticals Ltd. is a research-based organization specializing in the development, manufacture, and commercialization of prescription medicines and vaccines. The company’s portfolio spans multiple therapeutic areas, including anti-infectives, dermatology, gynecology, oncology, and respiratory health. Key products include Augmentin, Calpol, Ceftum, and Eltroxin. It maintains a significant presence in the vaccines sector, offering protection against diseases such as pneumococcal infection, hepatitis, and varicella. By integrating global research and development expertise, the entity focuses on delivering innovative treatments and improving patient outcomes. Its operations are supported by a robust supply chain and distribution infrastructure designed to provide broad access to essential medical products.

Recent filings

Filing Released Lang Actions
Action(s) initiated or orders passed
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) regarding a demand order received from a state GST authority. It details the nature of the tax demand, the authority involved, the date of receipt, and the company's response. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about a legal/tax matter, not a financial report or earnings release. It fits best under Regulatory Filings (RNS) as it is a compliance disclosure under SEBI regulations about a tax demand order.
2025-12-22 English
Disclosure under Regulation 30
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) regarding a regulatory demand order from the West Bengal State GST authorities. It details the nature of the demand, the authority involved, the date of receipt, and the company's response. The document is short (2454 characters) and does not contain any financial statements, management discussion, or detailed report content. It is a regulatory announcement about a legal/tax matter rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-22 English
Action(s) initiated or orders passed
Legal Proceedings Report Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a court decree received from the Court of Small Causes, Bombay, related to a legal matter involving a financial demand. The document does not contain financial statements or detailed financial analysis but is a regulatory announcement about a legal proceeding affecting the company. It is not an audit report, annual report, or earnings release. The content fits best under Legal Proceedings Report (LTR) as it updates on a significant lawsuit or regulatory action involving the company.
2025-12-18 English
As per attachment
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) disclosing a court decree received by GlaxoSmithKline Pharmaceuticals Limited. It references Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content details a legal decree from the Court of Small Causes, Bombay, involving a financial demand related to a long-past matter. The document is a regulatory announcement about a legal proceeding and does not contain financial statements, management discussion, or detailed report data. It is not a full audit report or annual/interim report, nor is it a voting result or capital change. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a legal matter that does not fit other specific categories.
2025-12-18 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges disclosing an order received from a tax authority regarding a GST demand for a specific fiscal year. It references a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements, indicating it is a regulatory announcement. The content is about a tax demand order and its details, not a financial report, earnings release, or management discussion. The document length is short (2252 characters) and it is a disclosure of a regulatory event rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-12 English
As per attachment
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges referencing a regulatory order received from tax authorities regarding a GST demand for a specific fiscal year. It provides details about the order, the authority involved, and the company's response. The document is short (2252 characters) and serves as a regulatory announcement of a legal/tax matter rather than a financial report or detailed audit. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-12-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.